Melanoma

Trial DANTE
Cancer Type Melanoma
Hospital(s) Belfast City Hospital
Information

A randomised phase III trial to evaluate the Duration of ANti-PD1 monoclonal antibody Treatment in patients with metastatic mElanoma

Trial INTERIM
Cancer Type Melanoma
Hospital(s) Belfast City Hospital
Information

A randomised phase II feasibility study of INTERmittent versus continuous dosing or oral targeted combination therapy In patients with BRAFV600 mutant stage 3 unresectable or metastatic Melanoma

Click Here to view CancerHelpUK trial summary